Np95 is regulated by E1A during mitotic reactivation of terminally differentiated cells and is essential for S phase entry

Terminal differentiation exerts a remarkably tight control on cell proliferation. However, the oncogenic products of DNA tumor viruses, such as adenovirus E1A, can force postmitotic cells to proliferate, thus representing a powerful tool to study progression into S phase. In this study, we identified the gene encoding Np95, a murine nuclear phosphoprotein, as an early target of E1A-induced transcriptional events. In terminally differentiated (TD) cells, the activation of Np95 was specifically induced by E1A, but not by overexpression of E2F-1 or of the cyclin E (cycE)–cyclin-dependent kinase 2 (cdk2) complex. In addition, the concomitant expression of Np95 and of cycE–cdk2 was alone sufficient to induce S phase in TD cells. In NIH-3T3 cells, the expression of Np95 was tightly regulated during the cell cycle, and its functional ablation resulted in abrogation of DNA synthesis. Thus, expression of Np95 is essential for S phase entry. Previous evidence suggested that E1A, in addition to its well characterized effects on the pRb/E2F-1 pathway, activates a parallel and complementary pathway that is also required for the reentry in S phase of TD cells (Tiainen, M., D. Spitkousky, P. Jansen-Dürr, A. Sacchi, and M. Crescenzi. 1996. Mol. Cell. Biol. 16:5302–5312). From our results, Np95 appears to possess all the characteristics to represent the first molecular determinant identified in this pathway.

[1]  M. Tiainen,et al.  Reconstitution of Cyclin D1-Associated Kinase Activity Drives Terminally Differentiated Cells into the Cell Cycle , 2001, Molecular and Cellular Biology.

[2]  Hiroshi Watanabe,et al.  Dynamic changes in subnuclear NP95 location during the cell cycle and its spatial relationship with DNA replication foci. , 2001, Experimental cell research.

[3]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[4]  D. Dean,et al.  Role of the LXCXE Binding Site in Rb Function , 2000, Molecular and Cellular Biology.

[5]  M. Muto,et al.  Temporal and spatial localization of novel nuclear protein NP95 in mitotic and meiotic cells. , 2000, Cell structure and function.

[6]  T. Hunter,et al.  P21 and Retinoblastoma Protein Control the Absence of DNA Replication in Terminally Differentiated Muscle Cells , 2000, The Journal of cell biology.

[7]  B. Amati,et al.  Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1 , 2000, Oncogene.

[8]  K. Helin,et al.  The E2F transcription factors: key regulators of cell proliferation. , 2000, Biochimica et biophysica acta.

[9]  K. Helin,et al.  E2F activates late-G1 events but cannot replace E1A in inducing S phase in terminally differentiated skeletal muscle cells , 1999, Oncogene.

[10]  K. Mita,et al.  Cloning and mapping of Np95 gene which encodes a novel nuclear protein associated with cell proliferation , 1998, Mammalian Genome.

[11]  B. Amati,et al.  A novel function of adenovirus E1A is required to overcome growth arrest by the CDK2 inhibitor p27Kip1 , 1998, The EMBO journal.

[12]  A. Giordano,et al.  Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation. , 1998, Cancer research.

[13]  L. Kedes,et al.  Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. , 1997, Molecular cell.

[14]  J. Nevins,et al.  Distinct roles for E2F proteins in cell growth control and apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Eckner.  p300 and CBP as transcriptional regulators and targets of oncogenic events. , 1996, Biological chemistry.

[16]  M. Tiainen,et al.  Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue-specific genes by separable mechanisms , 1996, Molecular and cellular biology.

[17]  M. Tiainen,et al.  Terminally differentiated skeletal myotubes are not confined to G0 but can enter G1 upon growth factor stimulation. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[18]  Aaron P. Campbell,et al.  Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Bartek,et al.  Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression , 1996, Molecular and cellular biology.

[20]  K. Hirokawa,et al.  The characterization of the monoclonal antibody Th‐10a, specific for a nuclear protein appearing in the S phase of the cell cycle in normal thymocytes and its unregulated expression in lymphoma cell lines , 1995, Cell proliferation.

[21]  B. Stillman,et al.  Cold Spring Harbor Laboratory , 1995, Molecular medicine.

[22]  D. Livingston,et al.  A family of transcriptional adaptor proteins targeted by the E1A oncoprotein , 1995, Nature.

[23]  M. Crescenzi,et al.  Mitotic cycle reactivation in terminally differentiated cells by adenovirus infection , 1995, Journal of cellular physiology.

[24]  W. Sellers,et al.  E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators , 1994, Cell.

[25]  L. Minichiello,et al.  Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF‐dependent mitogenic signals. , 1993, The EMBO journal.

[26]  J. Nevins,et al.  Expression of transcription factor E2F1 induces quiescent cells to enter S phase , 1993, Nature.

[27]  P. Yaciuk,et al.  Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth , 1993, Journal of virology.

[28]  P. Yaciuk,et al.  Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity , 1990, Journal of virology.

[29]  J. Nevins.  Adenovirus E1A-dependent trans-activation of transcription. , 1990, Seminars in cancer biology.

[30]  R. Roberts,et al.  Different functional domains of the adenovirus E1A gene are involved in regulation of host cell cycle products , 1987, Molecular and cellular biology.

[31]  N. Jones,et al.  Transformation properties of type 5 adenovirus mutants that differentially express the E1A gene products. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[32]  N. Jones,et al.  Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells , 1979, Cell.

[33]  D. Yaffe,et al.  Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle , 1977, Nature.

[34]  F. Graham,et al.  Host-range mutants of adenovirus type 5 defective for growth in HeLa cells. , 1977, Virology.

[35]  K. Okazaki,et al.  Myogenesis: fusion, myosin synthesis, and the mitotic cycle. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Bronner,et al.  ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression. , 2000, Cancer research.

[37]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.